Last reviewed · How we verify
Enterococcus Prostatitis
Approved treatments
- Cefradex · Bristol-Myers Squibb
- Carboxybenzylpenicillin
- Cephradin · Sohag University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Enterococcus Prostatitis patent landscape — cliff calendar, originator estates, attackable patents
- Enterococcus Prostatitis treatment landscape brief
- Enterococcus Prostatitis treatment updates RSS
Frequently asked questions about Enterococcus Prostatitis
What drugs treat Enterococcus Prostatitis?
Tracked treatments include Cefradex, Carboxybenzylpenicillin, Cephradin.
What is the treatment for Enterococcus Prostatitis?
Standard treatment for Enterococcus Prostatitis includes Cefradex, Carboxybenzylpenicillin, Cephradin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Enterococcus Prostatitis patent cliff · Enterococcus Prostatitis CI report
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Carboxybenzylpenicillin
- Treatment: Cephradin · Sohag University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing